T‐cell exhaustion: characteristics, causes and conversion

Summary T‐cell exhaustion is characterized by the stepwise and progressive loss of T‐cell functions and can culminate in the physical deletion of the responding cells. Exhaustion is well‐defined during chronic lymphocytic choriomeningitis virus infection and commonly develops under conditions of antigen‐persistence, which occur following many chronic infections that are of significant public health concern including hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections, as well as during tumour outgrowth. Exhaustion is not a uniformly disabled setting as a gradation of phenotypic and functional defects can manifest, and these cells are distinct from prototypic effector, memory and also anergic T cells. We are gaining insights into the extrinsic and intrinsic factors that determine the severity of exhaustion. These include the duration and magnitude of antigenic activation, availability of CD4 T‐cell help, the levels of stimulatory and suppressive cytokines, as well as the expression of activatory and inhibitory receptors. More information is now becoming available regarding the molecular mechanisms that attenuate the responsiveness of exhausted T cells. As the parameters that dictate exhaustion are more thoroughly defined, this is fostering the development of methods that prevent and rejuvenate functionally inferior responses. In this article we discuss our current understanding of the properties of exhausted T cells and the mechanisms that promote and maintain this state.

[1]  N. Weng,et al.  IL‐21 preferentially enhances IL‐15‐mediated homeostatic proliferation of human CD28+ CD8 memory T cells throughout the adult age span , 2010, Journal of leukocyte biology.

[2]  J. Thierry-Mieg,et al.  Analysis of interleukin-21-induced Prdm1 gene regulation reveals functional cooperation of STAT3 and IRF4 transcription factors. , 2009, Immunity.

[3]  C. Tremblay,et al.  Dynamics and Consequences of IL-21 Production in HIV-Infected Individuals: A Longitudinal and Cross-Sectional Study , 2009, The Journal of Immunology.

[4]  A. Iwasaki,et al.  CTL mobilization to virus-infected tissue requires CD4+ T cell help , 2009, Nature.

[5]  C. Hallahan,et al.  Defective Human Immunodeficiency Virus-Specific CD8+ T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy , 2009, Journal of Virology.

[6]  E. Wherry,et al.  A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection. , 2009, Immunity.

[7]  E. Zúñiga,et al.  Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo. , 2009, Immunity.

[8]  H. Jessen,et al.  IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. , 2009, Blood.

[9]  B. McMahon,et al.  Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells , 2009, Journal of Virology.

[10]  Russell G. Jones,et al.  Enhancing CD8 T-cell memory by modulating fatty acid metabolism , 2009, Nature.

[11]  A. Zajac,et al.  A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection , 2009, Science.

[12]  J. Weber,et al.  IL-21R on T Cells Is Critical for Sustained Functionality and Control of Chronic Viral Infection , 2009, Science.

[13]  K. Sauer,et al.  IL-21 Is Required to Control Chronic Viral Infection , 2009, Science.

[14]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[15]  Scott N. Mueller,et al.  High antigen levels are the cause of T cell exhaustion during chronic viral infection , 2009, Proceedings of the National Academy of Sciences.

[16]  R. Ahmed,et al.  mTOR regulates memory CD8 T cell differentiation , 2009, Nature.

[17]  E. Usherwood,et al.  Cutting Edge: IL-2 Immune Complexes As a Therapy for Persistent Virus Infection 1 , 2009, The Journal of Immunology.

[18]  Sang-Jun Ha,et al.  Visualizing Antigen-Specific and Infected Cells in Situ Predicts Outcomes in Early Viral Infection , 2009, Science.

[19]  G. Freeman,et al.  Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade , 2009, PLoS pathogens.

[20]  G. Freeman,et al.  IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection , 2008, Proceedings of the National Academy of Sciences.

[21]  G. Freeman,et al.  Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade , 2008, Nature.

[22]  D. Vignali,et al.  Interleukin‐35: odd one out or part of the family? , 2008, Immunological reviews.

[23]  R. Kaul,et al.  Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection , 2008, The Journal of experimental medicine.

[24]  G. Freeman,et al.  Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade , 2008, Proceedings of the National Academy of Sciences.

[25]  M. Sester,et al.  PD‐1 Expression and IL‐2 Loss of Cytomegalovirus‐ Specific T Cells Correlates with Viremia and Reversible Functional Anergy , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  J. McCune,et al.  Central Memory CD8+ T Cells Appear to Have a Shorter Lifespan and Reduced Abundance as a Function of HIV Disease Progression1 , 2008, The Journal of Immunology.

[27]  Kyong‐Mi Chang,et al.  Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. , 2008, Journal of hepatology.

[28]  G. Freeman,et al.  Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. , 2008, Gastroenterology.

[29]  W. Leonard,et al.  IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. , 2008, Blood.

[30]  C. Hunter,et al.  Advances in understanding the anti-inflammatory properties of IL-27. , 2008, Immunology letters.

[31]  A. Paiva,et al.  Differences in Hepatitis C Virus (HCV)-Specific CD8 T-Cell Phenotype during Pegylated Alpha Interferon and Ribavirin Treatment Are Related to Response to Antiviral Therapy in Patients Chronically Infected with HCV , 2008, Journal of Virology.

[32]  D. Fuchs,et al.  Immune Activation Driven by CTLA-4 Blockade Augments Viral Replication at Mucosal Sites in Simian Immunodeficiency Virus Infection1 , 2008, The Journal of Immunology.

[33]  D. McGavern,et al.  IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection , 2008, The Journal of experimental medicine.

[34]  D. Moskophidis,et al.  Control of Virus-Specific CD8+ T-Cell Exhaustion and Immune-Mediated Pathology by E3 Ubiquitin Ligase Cbl-b during Chronic Viral Infection , 2008, Journal of Virology.

[35]  Yan Zheng,et al.  Molecular regulation of T‐cell anergy , 2008, EMBO reports.

[36]  J. Svaren,et al.  Cbl-b Regulates Antigen-Induced TCR Down-Regulation and IFN-γ Production by Effector CD8 T Cells without Affecting Functional Avidity1 , 2007, The Journal of Immunology.

[37]  J. Schwaller,et al.  Programmed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression. , 2007, Blood.

[38]  E. Wherry,et al.  Molecular signature of CD8+ T cell exhaustion during chronic viral infection. , 2007, Immunity.

[39]  E. Rosenberg,et al.  Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction , 2007, Nature Immunology.

[40]  Joshy Jacob,et al.  Interleukin-10 plays an early role in generating virus-specific T cell anergy , 2006, BMC Immunology.

[41]  B. Palmer,et al.  Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction , 2007, Journal of Virology.

[42]  K. Schwarz,et al.  Differential role of IL‐2R signaling for CD8+ T cell responses in acute and chronic viral infections , 2007, European journal of immunology.

[43]  Annette Oxenius,et al.  Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection , 2007, Proceedings of the National Academy of Sciences.

[44]  A. Bertoletti,et al.  Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection , 2007, Journal of Virology.

[45]  G. Freeman,et al.  Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression , 2006, Journal of Virology.

[46]  R. Balderas,et al.  Corrigendum: Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction , 2006, Nature Medicine.

[47]  W. Haining,et al.  Resolution of a chronic viral infection after interleukin-10 receptor blockade , 2006, The Journal of experimental medicine.

[48]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[49]  R. Koup,et al.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection , 2006, The Journal of experimental medicine.

[50]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[51]  N. Paladino,et al.  Gender Susceptibility to Chronic Hepatitis C Virus Infection Associated with Interleukin 10 Promoter Polymorphism , 2006, Journal of Virology.

[52]  M. Massari,et al.  PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion , 2006, Journal of Virology.

[53]  David A Hildeman,et al.  Role of Bim in Regulating CD8+ T-Cell Responses during Chronic Viral Infection , 2006, Journal of Virology.

[54]  R. Flavell,et al.  Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent Mechanisms , 2006 .

[55]  R. Balderas,et al.  Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction , 2006, Nature Medicine.

[56]  A. Tyznik,et al.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells , 2006, Nature.

[57]  M. Bevan,et al.  Developing and maintaining protective CD8+ memory T cells , 2006, Immunological reviews.

[58]  D. McGavern,et al.  Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. , 2006, The Journal of clinical investigation.

[59]  Grégoire Altan-Bonnet,et al.  Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell–dendritic cell interaction , 2006, Nature.

[60]  R. Ahmed,et al.  Restoring function in exhausted CD8 T cells during chronic viral infection , 2006, Nature.

[61]  S. Robertson,et al.  CD8+ T-Cell Dysfunction due to Cytolytic Granule Deficiency in Persistent Friend Retrovirus Infection , 2005, Journal of Virology.

[62]  L. Teyton,et al.  Intrinsic Functional Dysregulation of CD4 T Cells Occurs Rapidly following Persistent Viral Infection , 2005, Journal of Virology.

[63]  P. Goepfert,et al.  Cutting Edge: Emergence of CD127high Functionally Competent Memory T Cells Is Compromised by High Viral Loads and Inadequate T Cell Help1 , 2005, The Journal of Immunology.

[64]  P. Krebs,et al.  Rapid Functional Exhaustion and Deletion of CTL following Immunization with Recombinant Adenovirus1 , 2005, The Journal of Immunology.

[65]  E. Wherry,et al.  Antigen-independent memory CD8 T cells do not develop during chronic viral infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[66]  H. Takada,et al.  Dominant expression of interleukin‐10 and transforming growth factor‐β genes in activated T‐cells of chronic active epstein–barr virus infection , 2004, Journal of medical virology.

[67]  M. Bevan Helping the CD8+ T-cell response , 2004, Nature Reviews Immunology.

[68]  Aaruni Khanolkar,et al.  Maintenance, Loss, and Resurgence of T Cell Responses During Acute, Protracted, and Chronic Viral Infections1 , 2004, The Journal of Immunology.

[69]  Graeme E Price,et al.  Differential Tissue-Specific Regulation of Antiviral CD8+ T-Cell Immune Responses during Chronic Viral Infection , 2004, Journal of Virology.

[70]  C. D. Krause,et al.  Interleukin-10 and related cytokines and receptors. , 2004, Annual review of immunology.

[71]  P. Greenberg,et al.  Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. , 2004, Immunity.

[72]  M. Imawari,et al.  Hepatitis B core antigen stimulates interleukin‐10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection , 2004, Clinical and experimental immunology.

[73]  Alison Johnson,et al.  Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+ T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 , 2003, Journal of Virology.

[74]  Susanne Knapp,et al.  Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection , 2003, Immunogenetics.

[75]  E. Wherry,et al.  Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo , 2003, Nature Medicine.

[76]  E. Wherry,et al.  Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment , 2003, Journal of Virology.

[77]  C. Fathman,et al.  GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. , 2003, Immunity.

[78]  Urs Christen,et al.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.

[79]  A. Zajac,et al.  Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1 , 2003, The Journal of Immunology.

[80]  M. Massari,et al.  Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C , 2002, Journal of Virology.

[81]  K. Eguchi,et al.  Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus , 2002, American Journal of Gastroenterology.

[82]  A. King,et al.  Escaping High Viral Load Exhaustion , 2002, The Journal of experimental medicine.

[83]  B. Walker,et al.  Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus , 2001, Journal of Virology.

[84]  J. Altman,et al.  Antiviral Cd8+ T Cell Responses in Neonatal Mice , 2001, The Journal of experimental medicine.

[85]  R. Welsh Assessing Cd8 T Cell Number and Dysfunction in the Presence of Antigen , 2001, The Journal of experimental medicine.

[86]  M. Mulligan,et al.  A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon , 2000, Journal of Virology.

[87]  E. Rosenberg,et al.  Immune control of HIV-1 after early treatment of acute infection , 2000, Nature.

[88]  B. Walker,et al.  Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.

[89]  Mario Roederer,et al.  Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients , 1999, Nature Medicine.

[90]  J. Altman,et al.  Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function , 1998, The Journal of experimental medicine.

[91]  R. Zinkernagel,et al.  Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. , 1998, Immunity.

[92]  R. Zinkernagel,et al.  Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes , 1998, The Journal of experimental medicine.

[93]  J. Berzofsky,et al.  Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. , 1994, The Journal of clinical investigation.

[94]  A. Oxenius,et al.  On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection. , 2010, International immunology.

[95]  Antonio Polley,et al.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection , 2009, Nature Immunology.

[96]  P. Goepfert,et al.  Functionally competent antigen-specific CD127(hi) memory CD8+ T cells are preserved only in HIV-infected individuals receiving early treatment. , 2007, The Journal of infectious diseases.

[97]  R. Flavell,et al.  Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. , 2006, Immunity.

[98]  J. Lieberman,et al.  Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. , 2003, Blood.

[99]  A. King,et al.  Escaping High Viral Load Exhaustion: CD8 Cells with Altered Tetramer Binding in Chronic Hepatitis B Virus Infection , 2002 .

[100]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[101]  Rolf M. Zinkernagel,et al.  Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells , 1993, Nature.